Article date: September 1982
By: JP Kampmann, TL Svendsen, L Skovsted, Molholm JE Hansen, in Volume 14, Issue 3, pages 447-448
The potential influence of the selective beta 2‐adrenoceptor agonist terbutaline on the serum concentration of the thyroid hormones in humans was studied in 11 healthy euthyroid subjects. Five served as a control group without medication while six received 5 mg terbutaline three times daily for 2 weeks. No significant differences were found between the two groups by measuring the serum concentrations of thyroxine, triiodothyronine, reverse triiodothyronine and resin‐ triiodothyronine uptake. The use of a beta 2‐adrenergic receptor stimulating drug is relatively contraindicated in untreated thyrotoxicosis. This recommendation is based upon a summation of clinical adverse reactions and not due to an effect on the serum concentrations of thyroid hormones.
DOI: 10.1111/j.1365-2125.1982.tb02006.x
View this article